|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MSDS   | : | Dibenzo(1,2,5)thiadiazepine,
6,11-dihydro-11-(3-(dimethylamino)propyl)-6-methyl-,
5,5- dioxide
| | CAS   | : | 7200-23-9 | | SYNONYMS   | : | * 11-(3-(Dimethylamino)propyl)-6-methyl-6,11-dihydrodibenzo(1,2,5)thiadiaz
epine 5,5-dioxide
* 6-Methyl 11 (3-dimethylaminopropyl)dibenzo(c.f)(1,2,5)thiadiazepine
5,5-dioxyde
|
| |
|
|
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : HQ1828000
CHEMICAL NAME : Dibenzo(1,2,5)thiadiazepine,
6,11-dihydro-11-(3-(dimethylamino)propyl)-6-methyl-,
5,5- dioxide
CAS REGISTRY NUMBER : 7200-23-9
LAST UPDATED : 198305
DATA ITEMS CITED : 3
MOLECULAR FORMULA : C17-H21-N3-O2-S
MOLECULAR WEIGHT : 331.47
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* 11-(3-(Dimethylamino)propyl)-6-methyl-6,11-dihydrodibenzo(1,2,5)thiadiaz
epine 5,5-dioxide
* 6-Methyl 11 (3-dimethylaminopropyl)dibenzo(c.f)(1,2,5)thiadiazepine
5,5-dioxyde
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 240 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - changes in motor activity (specific assay)
Behavioral - ataxia
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,
France) V.1- 1943- Volume(issue)/page/year: 24,445,1966
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 23 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - changes in motor activity (specific assay)
Behavioral - ataxia
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,
France) V.1- 1943- Volume(issue)/page/year: 24,445,1966
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 380 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - changes in motor activity (specific assay)
Behavioral - ataxia
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,
France) V.1- 1943- Volume(issue)/page/year: 24,445,1966
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
Dibenzo(a,g)quinolizinium,5,6-dihydro-2,3,10,11-tetramethoxy-, iodide
| 131-04-4 |
|
Dibenzo(a,g)quinolizinium,8-ethyl-2,3,10,11-tetramethoxy-, sulfate (1:1),anhydride with propanoic acid
| 51865-95-3 |
|
Dibenzo(a,g)quinolizinium,8-methyl-2,3,10,11-tetramethoxy-, chloride
| 38989-38-7 |
|
6H-Dibenzo(a,g)quinolizinium,5,8,13,13a-tetrahydro-13-hydroxy-7-methyl-2,3,10,11-tetramethoxy-, iodide,(7-alpha,13-alpha,13a-alpha)-(+-)-
| 120021-24-1 |
|
6H-Dibenzo(a,g)quinolizinium,5,8,13,13a-tetrahydro-13-hydroxy-7-methyl-2,3,10,11-tetramethoxy-, iodide,(7-alpha,13-alpha,13a-beta)-(+-)-
| 120021-25-2 |
|
6H-Dibenzo(a,g)quinolizinium,5,8,13,13a-tetrahydro-7-methyl-2,3,10,11-tetramethoxy-, iodide, (+-)-
| 120052-37-1 |
|
Dibenzo(a,g)quinolizinium,2,3,10,11-tetramethoxy-8-methyl-, saltwithsulfoacetic acid (1:1)
| 38989-37-6 |
|
5H-Dibenzo(b,e)(1,4)diazepine,8-chloro-11-(4-methyl-1-piperazinyl)-
| 5786-21-0 |
|
6H-Dibenzo(a,g)quinolizin-13-ol,5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-,cis-(+-)-
| 59414-58-3 |
|
Dibenzo(b,e)selenepin-11-propylamine,6,11-dihydro-N,N-dimethyl-, maleate (1:1)
| 25354-27-2 |
|
Dibenzo(b,e)selenepin-delta(sup11(6H),gamma)-propylamine, N,N-dimethyl-,hydrochloride, (E)-
| 25341-18-8 |
|
Dibenzo(b,e)selenepin-delta(sup11(6H),gamma)-propylamine, N-methyl-, hydrochloride,(E)-
| 25354-28-3 |
|
Dibenzo(1,2,5)thiadiazepine,6,11-dihydro-11-(3-(dimethylamino)propyl)-6-methyl-,5,5- dioxide
| 7200-23-9 |
|
Dibenzo(b,f)(1,4)thiazepine,8-chloro-10,11-dihydro-10-(3-methylaminopropyl)-,dihydrobromide, hydrate
| 60816-68-4 |
|
Dibenzo(b,f)(1,4)thiazepine,2-chloro-11-((2-dimethylaminoethyl)methylamino)-
| 6550-57-8 |
|
Dibenzo(b,f)(1,4)thiazepine,2-chloro-11-(4-methyl-1-piperazinyl)-
| 2058-52-8 |
|
Dibenzo(b,f)(1,4)thiazepine,2-chloro-11-(4-methyl-1-piperazinyl)-, hydrochloride
| 4956-31-4 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-7-chloro-10-(2-(diethylamino)ethyl)-
| 4956-31-4 |
|
5H-Dibenzo(b,e)(1,4)diazepine,8-chloro-11-(4-methyl-1-piperazinyl)-, N-oxide
| 34233-69-7 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-8-chloro-10-((diethylamino)acetyl)-,hydrochloride
| 34233-69-7 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-8-chloro-10-(2-(dimethylamino)ethyl)-
| 34233-69-7 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-10-((diethylamino)acetyl)-,hydrochloride
| 34233-69-7 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-10-(2-(dimethylamino)ethyl)-
| 34233-69-7 |
|
Dibenzo(b,f)(1,4)thiazepine,10,11-dihydro-10-(2-(dimethylamino)ethyl)-8-methyl-
| 34233-69-7 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-11-ethoxy-6-methyl-, 5,5-dioxide
| 155444-02-3 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-11-methoxy-6-methyl-, 5,5-dioxide
| 155444-01-2 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-6-methyl-11-(1-methylethoxy)-,5,5-dioxide
| 155444-04-5 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-6-methyl-11-(2-(1-piperazinyl)ethoxy)-,5,5-dioxide,(Z)-2-butenedioate (1:1)
| 155444-13-6 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-6-methyl-11-(2-(1-piperidinyl)ethoxy)-,5,5-dioxide,(Z)-2-butenedioate (1:1)
| 155444-11-4 |
|
5H-Dibenzo(a,d)cyclohepten-5-one,methyl-10-(4-methyl-1-piperazinyl)-
| 56958-55-5 |
|
5H-Dibenzo(b,e)(1,4)diazepine, 2-chloro-11-phenyl-
| 32047-75-9 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-6-methyl-11-propoxy-, 5,5-dioxide
| 155444-03-4 |
|
Dibenzo(c,f)(1,2)thiazepine,6,11-dihydro-6-methyl-11-(2-(1-pyrrolidinyl)ethoxy)-,5,5-dioxide(Z)-2-butenedioate (1:1)
| 155444-09-0 |
|
Dibenzo(b,f)(1,4)thiazepine-10-ethylamine,10,11-dihydro-N,N-dimethyl-, monohydrochloride
| 155444-09-0 |
|
Dibenzo(b,f)(1,4)thiazepine,2-methyl-11-(4-methyl-1-piperazinyl)-
| 5800-19-1 |
|
Dibenzo(b,f)(1,4)thiazepine,11-(4-methyl-1-piperazinyl)-
| 1977-09-9 |
|
Dibenzo(b,f)(1,4)thiazepine-10-propylamine,10,11-dihydro-8-chloro-N,N-dimethyl-,monohydrobromide
| 1977-09-9 |
|
Dibenzo(b,f)(1,4)thiazepine-10-propylamine,10,11-dihydro-N,N-dimethyl-, monohydrobromide
| 1977-09-9 |
|
Dibenzo(c,f)(1,2)thiazepin-11-ol,6,11-dihydro-6-methyl-, 5,5-dioxide
| 26638-56-2 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one, 8-amino-
| 105554-89-0 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,2-chloro-10-(2-(dimethylamino)ethyl)-
| 105554-89-0 |
|
5H-Dibenzo(d,f)(1,3)diazepine, 6-(diethylamino)-,hydrochloride
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,6-chloro-10-(2-(dimethylamino)ethyl)-
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,7-chloro-10-(2-(dimethylamino)ethyl)-
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,8-chloro-10-(2-(dimethylamino)ethyl)-
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,2,4-dichloro-10-(2-(dimethylamino)ethyl)-
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,10-(2-(diethylamino)ethyl)-8-methyl-
| 2880-34-4 |
|
Dibenzo(b,f)(1,4)thiazepin-11-one,10,11-dihydro-7-chloro-10-(2-(dimethylamino)ethyl)-S,S- dioxide
| 19190-30-8 |
|
Dibenzo(b,f)(1,4)thiazepin-11-one,10,11-dihydro-7-chloro-10-(2-(dimethylamino)ethyl)-,hydrochloride
| 78110-21-1 |
|
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one,10-(2-(dimethylamino)ethyl)-
| 78110-21-1 |
|
|
|
|
|